126 related articles for article (PubMed ID: 29070780)
1. No change in the prevalence of latent prostate cancer over the last 10 years: a forensic autopsy study in Japan.
Hitosugi M; Mukaisho K; Kido M; Kamimura S; Furukawa S; Sugihara H
Biomed Res; 2017; 38(5):307-312. PubMed ID: 29070780
[TBL] [Abstract][Full Text] [Related]
2. Latent prostate cancer in Japanese men who die unnatural deaths: A forensic autopsy study.
Kido M; Hitosugi M; Ishii K; Kamimura S; Joh K
Prostate; 2015 Jun; 75(9):917-22. PubMed ID: 25728717
[TBL] [Abstract][Full Text] [Related]
3. Forensic Autopsies can Determine Latent Prostate Cancer Prevalence.
Takaso M; Hitosugi M; Nakagawa R; Mukaisho K; Moriguchi S; Koh M; Sugihara H
J Forensic Sci; 2020 Sep; 65(5):1557-1562. PubMed ID: 32501618
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the incidence of latent prostate cancer detected at autopsy before and after the prostate specific antigen era.
Konety BR; Bird VY; Deorah S; Dahmoush L
J Urol; 2005 Nov; 174(5):1785-8; discussion 1788. PubMed ID: 16217287
[TBL] [Abstract][Full Text] [Related]
5. Latent prostate cancer among Japanese males: a bibliometric study of autopsy reports from 1980-2016.
Takeshima Y; Suzuki M; Miyakawa J; Tsuru I; Yamada Y; Nakamura M; Sato Y; Kawai T; Yamada D; Morikawa T; Kume H
Jpn J Clin Oncol; 2021 Jan; 51(1):156-159. PubMed ID: 32875336
[TBL] [Abstract][Full Text] [Related]
6. Not all gleason pattern 4 prostate cancers are created equal: A study of latent prostatic carcinomas in a cystoprostatectomy and autopsy series.
Siadat F; Sykes J; Zlotta AR; Aldaoud N; Egawa S; Pushkar D; Kuk C; Bristow RG; Montironi R; van der Kwast T
Prostate; 2015 Sep; 75(12):1277-84. PubMed ID: 25963383
[TBL] [Abstract][Full Text] [Related]
7. Time Trends in Histological Features of Latent Prostate Cancer in Japan.
Kimura T; Takahashi H; Okayasu M; Kido M; Inaba H; Kuruma H; Yamamoto T; Furusato B; Furusato M; Wada T; Egawa S
J Urol; 2016 May; 195(5):1415-1420. PubMed ID: 26678955
[TBL] [Abstract][Full Text] [Related]
8. "More men die with prostate cancer than because of it" - an old adage that still holds true in the 21st century.
C J; Y P; Sf B; Rj B
Cancer Treat Res Commun; 2021; 26():100225. PubMed ID: 33360667
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of prostate cancer on autopsy: cross-sectional study on unscreened Caucasian and Asian men.
Zlotta AR; Egawa S; Pushkar D; Govorov A; Kimura T; Kido M; Takahashi H; Kuk C; Kovylina M; Aldaoud N; Fleshner N; Finelli A; Klotz L; Sykes J; Lockwood G; van der Kwast TH
J Natl Cancer Inst; 2013 Jul; 105(14):1050-8. PubMed ID: 23847245
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of prostate cancer at autopsy in Nigeria-A preliminary report.
Bosland MC; Nettey OS; Phillips AA; Anunobi CC; Akinloye O; Ekanem IA; Bassey IE; Mehta V; Macias V; van der Kwast TH; Murphy AB
Prostate; 2021 Jun; 81(9):553-559. PubMed ID: 33905137
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of prostate cancer across the globe: what can autopsy studies teach us about this peculiar disease?
Zlotta AR; Kuk C
Arch Esp Urol; 2014 Jun; 67(5):400-8. PubMed ID: 24914839
[TBL] [Abstract][Full Text] [Related]
12. The frequency of latent prostatic carcinoma in young males: the Japanese experience.
Shiraishi T; Watanabe M; Matsuura H; Kusano I; Yatani R; Stemmermann GN
In Vivo; 1994; 8(3):445-7. PubMed ID: 7803732
[TBL] [Abstract][Full Text] [Related]
13. Changes in baseline PSA levels in Japanese men from 1988 to 2003.
Ohi M; Ito K; Yamamoto T; Miyakubo M; Takechi H; Kubota Y; Suzuki K
Urology; 2008 Jul; 72(1):95-8. PubMed ID: 18455775
[TBL] [Abstract][Full Text] [Related]
14. TMPRSS2 Met160Val polymorphism: significant association with sporadic prostate cancer, but not with latent prostate cancer in Japanese men.
Maekawa S; Suzuki M; Arai T; Suzuki M; Kato M; Morikawa T; Kasuya Y; Kume H; Kitamura T; Homma Y
Int J Urol; 2014 Dec; 21(12):1234-8. PubMed ID: 25040002
[TBL] [Abstract][Full Text] [Related]
15. Trends in frequency of latent prostate carcinoma in Japan from 1965-1979 to 1982-1986.
Yatani R; Shiraishi T; Nakakuki K; Kusano I; Takanari H; Hayashi T; Stemmermann GN
J Natl Cancer Inst; 1988 Jul; 80(9):683-7. PubMed ID: 3373558
[TBL] [Abstract][Full Text] [Related]
16. Active surveillance criteria for prostate cancer: can they be applied to Japanese patients?
Goto Y; Nozumi K; Miyazaki K; Matsumoto A; Inoue A; Kito H; Hasegawa N; Nagata M; Kakuta Y; Suzuki H; Yamaguchi K
Int J Urol; 2012 Feb; 19(2):163-6. PubMed ID: 22070372
[TBL] [Abstract][Full Text] [Related]
17. Screening for prostate cancer using prostate-specific antigen testing in Japanese men on hemodialysis.
Kurahashi T; Miyake H; Shinozaki M; Oka N; Takenaka A; Hara I; Matsumura Y; Fujisawa M
Int Urol Nephrol; 2008; 40(2):345-9. PubMed ID: 17619159
[TBL] [Abstract][Full Text] [Related]
18. [Chronological changes of incidence rates, clinical stages and pathological differentiation of prostate cancer in Gunma Prefecture, Japan].
Nakata S; Ohtake N; Kubota Y; Ito K; Suzuki K; Yamanaka H;
Hinyokika Kiyo; 2004 Mar; 50(3):165-70. PubMed ID: 15148767
[TBL] [Abstract][Full Text] [Related]
19. A prospective comparison of prostate cancer at autopsy and as a clinical event: the Hawaii Japanese experience.
Stemmermann GN; Nomura AM; Chyou PH; Yatani R
Cancer Epidemiol Biomarkers Prev; 1992; 1(3):189-93. PubMed ID: 1306104
[TBL] [Abstract][Full Text] [Related]
20. Prostate carcinoma detection and increased prostate-specific antigen levels after 4 years in Dutch and Japanese males who had no evidence of disease at initial screening.
Ito K; Raaijmakers R; Roobol M; Wildhagen M; Yamanaka H; Schröder FH
Cancer; 2005 Jan; 103(2):242-50. PubMed ID: 15578715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
